| Pathways of progression from intraductal papillary mucinous neoplasm to pancreatic ductal adenocarcinoma based on molecular features Y Omori, Y Ono, M Tanino, H Karasaki, H Yamaguchi, T Furukawa, ... Gastroenterology 156 (3), 647-661. e2, 2019 | 164 | 2019 |
| The functions and unique features of LncRNAs in cancer development and tumorigenesis K Taniue, N Akimitsu International journal of molecular sciences 22 (2), 632, 2021 | 163 | 2021 |
| Long noncoding RNA UPAT promotes colon tumorigenesis by inhibiting degradation of UHRF1 K Taniue, A Kurimoto, H Sugimasa, E Nasu, Y Takeda, K Iwasaki, ... Proceedings of the National Academy of Sciences 113 (5), 1273-1278, 2016 | 162 | 2016 |
| Identification of a link between Wnt/β-catenin signalling and the cell fusion pathway K Matsuura, T Jigami, K Taniue, Y Morishita, S Adachi, T Senda, ... Nature communications 2 (1), 548, 2011 | 115 | 2011 |
| The miR-363-GATA6-Lgr5 pathway is critical for colorectal tumourigenesis S Tsuji, Y Kawasaki, S Furukawa, K Taniue, T Hayashi, M Okuno, ... Nature communications 5 (1), 3150, 2014 | 104 | 2014 |
| Aberrant phase separation and cancer K Taniue, N Akimitsu The FEBS journal 289 (1), 17-39, 2022 | 73 | 2022 |
| ASBEL–TCF3 complex is required for the tumorigenicity of colorectal cancer cells K Taniue, A Kurimoto, Y Takeda, T Nagashima, M Okada-Hatakeyama, ... Proceedings of the National Academy of Sciences 113 (45), 12739-12744, 2016 | 63 | 2016 |
| Fusion genes and RNAs in cancer development K Taniue, N Akimitsu Non-Coding RNA 7 (1), 10, 2021 | 54 | 2021 |
| A member of the ETS family, EHF, and the ATPase RUVBL1 inhibit p53‐mediated apoptosis K Taniue, T Oda, T Hayashi, M Okuno, T Akiyama EMBO reports 12 (7), 682-689, 2011 | 50 | 2011 |
| The pleiotrophin-ALK axis is required for tumorigenicity of glioblastoma stem cells R Koyama-Nasu, R Haruta, Y Nasu-Nishimura, K Taniue, Y Katou, ... Oncogene 33 (17), 2236-2244, 2014 | 45 | 2014 |
| Heterogeneous nuclear ribonucleoprotein K upregulates the kinetochore complex component NUF2 and promotes the tumorigenicity of colon cancer cells H Sugimasa, K Taniue, A Kurimoto, Y Takeda, Y Kawasaki, T Akiyama Biochemical and biophysical research communications 459 (1), 29-35, 2015 | 39 | 2015 |
| UHRF1-KAT7-mediated regulation of TUSC3 expression via histone methylation/acetylation is critical for the proliferation of colon cancer cells K Taniue, T Hayashi, Y Kamoshida, A Kurimoto, Y Takeda, L Negishi, ... Oncogene 39 (5), 1018-1030, 2020 | 33 | 2020 |
| ASBEL, an ANA/BTG3 antisense transcript required for tumorigenicity of ovarian carcinoma S Yanagida, K Taniue, H Sugimasa, E Nasu, Y Takeda, M Kobayashi, ... Scientific reports 3 (1), 1305, 2013 | 30 | 2013 |
| Digital PCR-based plasma cell-free DNA mutation analysis for early-stage pancreatic tumor diagnosis and surveillance T Okada, Y Mizukami, Y Ono, H Sato, A Hayashi, H Kawabata, K Koizumi, ... Journal of Gastroenterology 55, 1183-1193, 2020 | 29 | 2020 |
| Metabolic labeling of RNA using multiple ribonucleoside analogs enables the simultaneous evaluation of RNA synthesis and degradation rates K Kawata, H Wakida, T Yamada, K Taniue, H Han, M Seki, Y Suzuki, ... Genome Research 30 (10), 1481-1491, 2020 | 28 | 2020 |
| PIK3CA and KRAS mutations in cell free circulating DNA are useful markers for monitoring ovarian clear cell carcinoma A Morikawa, T Hayashi, N Shimizu, M Kobayashi, K Taniue, A Takahashi, ... Oncotarget 9 (20), 15266, 2018 | 27 | 2018 |
| Systematic analysis of targets of pumilio-mediated mRNA decay reveals that PUM1 repression by DNA damage activates translesion synthesis T Yamada, N Imamachi, K Imamura, K Taniue, T Kawamura, Y Suzuki, ... Cell Reports 31 (5), 2020 | 26 | 2020 |
| RNA exosome component EXOSC4 amplified in multiple cancer types is required for the cancer cell survival K Taniue, T Tanu, Y Shimoura, S Mitsutomi, H Han, R Kakisaka, Y Ono, ... International journal of molecular sciences 23 (1), 496, 2022 | 22 | 2022 |
| Long non-coding RNAs in epithelial-mesenchymal transition of pancreatic cancer K Takahashi, K Taniue, Y Ono, M Fujiya, Y Mizukami, T Okumura Frontiers in Molecular Biosciences 8, 717890, 2021 | 21 | 2021 |
| PCDH10 is required for the tumorigenicity of glioblastoma cells K Echizen, M Nakada, T Hayashi, H Sabit, T Furuta, M Nakai, ... Biochemical and biophysical research communications 444 (1), 13-18, 2014 | 21 | 2014 |
Nobuyoshi Akimitsuthe university of tokyo在 ric.u-tokyo.ac.jp 的电子邮件经过验证
